0001493152-20-007826.txt : 20200506 0001493152-20-007826.hdr.sgml : 20200506 20200506161035 ACCESSION NUMBER: 0001493152-20-007826 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200506 DATE AS OF CHANGE: 20200506 EFFECTIVENESS DATE: 20200506 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ORAGENICS INC CENTRAL INDEX KEY: 0001174940 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 593410522 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-366416 FILM NUMBER: 20852705 BUSINESS ADDRESS: STREET 1: 4902 EISENHOWER BLVD STREET 2: SUITE 125 CITY: TAMPA STATE: FL ZIP: 33634 BUSINESS PHONE: 8132867900 MAIL ADDRESS: STREET 1: 4902 EISENHOWER BLVD STREET 2: SUITE 125 CITY: TAMPA STATE: FL ZIP: 33634 D 1 primary_doc.xml X0708 D LIVE 0001174940 ORAGENICS INC 4902 EISENHOWER BOULEVARD SUITE 125 TAMPA FL FLORIDA 33634 813-286-7900 FLORIDA Oragen, Inc. None Corporation true Alan Joslyn 4902 Eisenhower Boulevard Suite 125 Tampa FL FLORIDA 33634 Executive Officer Director Michael Sullivan 4902 Eisenhower Boulevard Suite 125 Tampa FL FLORIDA 33634 Executive Officer Frederick Telling 4902 Eisenhower Boulevard Suite 125 Tampa FL FLORIDA 33634 Director Charles Pope 4902 Eisenhower Boulevard Suite 125 Tampa FL FLORIDA 33634 Director Robert Koski 4902 Eisenhower Boulevard Suite 125 Tampa FL FLORIDA 33634 Director Alan Dunton 4902 Eisenhower Boulevard Suite 125 Tampa FL FLORIDA 33634 Director Biotechnology No Revenues 06b false 2020-05-01 false true true true true The consideration for the acquisition consisted of (i) $1,925,000 (less payment of certain liabilities), (ii) 9,200,000 shares of common stock; (iii) warrants to purchase 9,200,000 shares of common stock; and (iv) potential contingent consideration. 0 Indefinite 4600000 Indefinite false 1 0 0 0 false ORAGENICS INC /s/ Michael Sullivan Michael Sullivan Chief Financial Officer 2020-05-06